Statin Reloading before Noncardiac Surgery: A Simple, Safe and Effective Approach for Reducing the Risk of Perioperative Myocardial Infarction

Colivicchi, Furio

doi:10.1159/000381178

Cardiology

2015

DOI: 10.1159/000381178

|View full text |Cite

Statin Reloading before Noncardiac Surgery: A Simple, Safe and Effective Approach for Reducing the Risk of Perioperative Myocardial Infarction

Furio Colivicchi

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2018

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Management Strategies for Noncardiac Surgery Following a Coronary Artery Event

Whayne

Saha

2018

Curr Cardiol Rep

View full text Add to dashboard Cite

High functional capacity improves cardiovascular (CV) risk; at least 4.0 metabolic equivalents (METs) on stress test are favorable. Risk scores can suggest need for further evaluation. Coronary angiography prior to surgery usually is not indicated since revascularization shows disappointing CV risk reduction results. Due to high association of peripheral arterial disease (PAD) with coronary artery disease (CAD), low ankle-brachial index (ABI) indicates increased CV risk. New perioperative beta blockade has shown disappointing benefit, but if ongoing should be continued. De novo perioperative beta blockade is for the highest CV risk patient undergoing noncardiac vascular surgery. Good evidence supports CV risk reduction from new or existing statin in the perioperative period, especially for the diabetic. Diabetics should also be on an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) secondarily, during the perioperative period to decrease 30-day perioperative mortality. Optimal timing of elective noncardiac surgery following a coronary artery event appears to be 180 days with CV risk decreased by a statin and an ACEI or an ARB.

show abstract

Management Strategies for Noncardiac Surgery Following a Coronary Artery Event

Whayne

Saha

2018

Curr Cardiol Rep

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Statin Reloading before Noncardiac Surgery: A Simple, Safe and Effective Approach for Reducing the Risk of Perioperative Myocardial Infarction

Cited by 1 publication

References 16 publications

Management Strategies for Noncardiac Surgery Following a Coronary Artery Event

Management Strategies for Noncardiac Surgery Following a Coronary Artery Event

Contact Info

Product

Resources

About